Poster # 2255 PET/CT Response Predicts Histopathologic Response After Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer

Presenter: Michael Chuong, MD


Abstract:


E-mail a friend about this poster:
Enter email address: